MST1R and neurodegenerative disease: Therapeutic strategies that engage in the switch from a pro-inflammatory phenotype to a quiescent M2-like phenotype or the activation of Ron in the CNS may have the potential to alleviate the uncontrolled progression of inflammation underlying various neurodegenerative diseases.